Bristol Myers Squibb Co

USPTO Trademark & Patent Filings

Bristol Myers Squibb Co
Trademark Applications
Mark Image

Registration | Serial
Trademark
Application Date
BRAPIXA
"BRAPIXA"
77279364
BRAPIXA
2007-09-14
IPILIMUMAB
"IPILIMUMAB"
3677086 77273787
IPILIMUMAB
2007-09-07
TYPE 2 AND YOU
"TYPE 2 AND YOU"
77271715
TYPE 2 AND YOU
2007-09-05
IPI-CARES
"IPI-CARES"
77267961
IPI-CARES
2007-08-30
IPI-CARE
"IPI-CARE"
77265103
IPI-CARE
2007-08-27
GOVEXUL
"GOVEXUL"
77260572
GOVEXUL
2007-08-21
EVNEN
"EVNEN"
77260576
EVNEN
2007-08-21
ORTUNIT
"ORTUNIT"
77260551
ORTUNIT
2007-08-21
OZIMLA
"OZIMLA"
77260556
OZIMLA
2007-08-21
OPLICIM
"OPLICIM"
77260565
OPLICIM
2007-08-21
COMMENCE NEW PATIENT REIMBURSEMENT PROGRAM FOR ORENCIA
"COMMENCE NEW PATIENT REIMBURSEMENT PROGRAM FOR ORENCIA"
77259414
COMMENCE NEW PATIENT REIMBURSEMENT PROGRAM FOR ORENCIA
2007-08-20
COMMENCE
"COMMENCE"
77251299
COMMENCE
2007-08-09
ARM
"ARM"
77251385
ARM
2007-08-09
I CAN WITH RA IN THE KITCHEN
"I CAN WITH RA IN THE KITCHEN"
3928840 77248008
I CAN WITH RA IN THE KITCHEN
2007-08-06
I CAN WITH RA
"I CAN WITH RA"
4031842 77248014
I CAN WITH RA
2007-08-06
ENLITE THE ESSENTIAL BREAST CANCER RESOURCE
"ENLITE THE ESSENTIAL BREAST CANCER RESOURCE"
77238236
ENLITE THE ESSENTIAL BREAST CANCER RESOURCE
2007-07-25
ADJUST ABATACEPT STUDY TO DETERMINE THE EFFECTIVENESS IN PREVENTING THE DEVELOPMENT OF RA IN PATIENTS WITH UNDIFFERENTIATED INFL
"ADJUST ABATACEPT STUDY TO DETERMINE THE EFFECTIVENESS IN PREVENTING THE DEVELOPMENT OF RA IN PATIENTS WITH UNDIFFERENTIATED INFL"
4142864 77233550
ADJUST ABATACEPT STUDY TO DETERMINE THE EFFECTIVENESS IN PREVENTING THE DEVELOPMENT OF RA IN PATIENTS WITH UNDIFFERENTIATED INFL
2007-07-19
IMMPACT IMMUNO-INFORMATION TO SHIFT THE PARADIGM IN CANCER TREATMENT
"IMMPACT IMMUNO-INFORMATION TO SHIFT THE PARADIGM IN CANCER TREATMENT"
77230479
IMMPACT IMMUNO-INFORMATION TO SHIFT THE PARADIGM IN CANCER TREATMENT
2007-07-16
ORENCIA ZENGRIP
"ORENCIA ZENGRIP"
77228095
ORENCIA ZENGRIP
2007-07-12
T.A.L.K TAKE ACTION. LEARN. KNOW HOW.
"T.A.L.K TAKE ACTION. LEARN. KNOW HOW."
3861226 77227094
T.A.L.K TAKE ACTION. LEARN. KNOW HOW.
2007-07-11
ORENCIA FEATHERFIT
"ORENCIA FEATHERFIT"
77224354
ORENCIA FEATHERFIT
2007-07-09
ORENCIA ZENSURE
"ORENCIA ZENSURE"
77224360
ORENCIA ZENSURE
2007-07-09
ORENCIA FEATHERJECT
"ORENCIA FEATHERJECT"
77224355
ORENCIA FEATHERJECT
2007-07-09
ORENCIA FREEVERSE
"ORENCIA FREEVERSE"
77224362
ORENCIA FREEVERSE
2007-07-09
ORENCIA FEATHERJET
"ORENCIA FEATHERJET"
77224356
ORENCIA FEATHERJET
2007-07-09
ORENCIA SURESPRING
"ORENCIA SURESPRING"
77224364
ORENCIA SURESPRING
2007-07-09
ORENCIA GLISSADER
"ORENCIA GLISSADER"
77224357
ORENCIA GLISSADER
2007-07-09
ORENCIA HANDGLIDE
"ORENCIA HANDGLIDE"
77224358
ORENCIA HANDGLIDE
2007-07-09
ORENCIA DOSALIGN
"ORENCIA DOSALIGN"
77224353
ORENCIA DOSALIGN
2007-07-09
ORENCIA SWIFTDOSE
"ORENCIA SWIFTDOSE"
77224359
ORENCIA SWIFTDOSE
2007-07-09
ORENCIA COMFORTSHOT
"ORENCIA COMFORTSHOT"
77218652
ORENCIA COMFORTSHOT
2007-06-29
ORENCIA DEXIGN
"ORENCIA DEXIGN"
77218655
ORENCIA DEXIGN
2007-06-29
ORENCIA EFFORTEASE
"ORENCIA EFFORTEASE"
77218638
ORENCIA EFFORTEASE
2007-06-29
ORENCIA ZENJEX
"ORENCIA ZENJEX"
77218662
ORENCIA ZENJEX
2007-06-29
ORENCIA DIRECTJECT
"ORENCIA DIRECTJECT"
77218643
ORENCIA DIRECTJECT
2007-06-29
ORENCIA COMFORTDOSE
"ORENCIA COMFORTDOSE"
77218666
ORENCIA COMFORTDOSE
2007-06-29
ORENCIA FITJECT
"ORENCIA FITJECT"
77218648
ORENCIA FITJECT
2007-06-29
ORENCIA SPRINGJECT
"ORENCIA SPRINGJECT"
77218650
ORENCIA SPRINGJECT
2007-06-29
CHALLENGING CASES IN INITIAL THERAPY
"CHALLENGING CASES IN INITIAL THERAPY"
77217896
CHALLENGING CASES IN INITIAL THERAPY
2007-06-28
ITHERAPY
"ITHERAPY"
77217883
ITHERAPY
2007-06-28
AGREE
"AGREE"
3931309 77216439
AGREE
2007-06-27
ADVOCATE
"ADVOCATE"
77204656
ADVOCATE
2007-06-13
NURSE PARTNERS EDUCATE/EMPOWER
"NURSE PARTNERS EDUCATE/EMPOWER"
3600889 77205121
NURSE PARTNERS EDUCATE/EMPOWER
2007-06-13
INTUID
"INTUID"
77192703
INTUID
2007-05-30
ASSESS
"ASSESS"
77189080
ASSESS
2007-05-24
ARISTOCRAT
"ARISTOCRAT"
77189070
ARISTOCRAT
2007-05-24
AVERROES
"AVERROES"
4088156 77180089
AVERROES
2007-05-14
PARTNERS IN DIABETES
"PARTNERS IN DIABETES"
77169792
PARTNERS IN DIABETES
2007-05-01
"Symbol/Image"
77167297
Symbol/Image
2007-04-27
"Symbol/Image"
77167327
Symbol/Image
2007-04-27
PICOT PLUS
"PICOT PLUS"
77165386
PICOT PLUS
2007-04-25
MANAGE MD'S ANSWERS GAGE TREATMENT PRACTICES
"MANAGE MD'S ANSWERS GAGE TREATMENT PRACTICES"
77158394
MANAGE MD'S ANSWERS GAGE TREATMENT PRACTICES
2007-04-17
REVIPIC
"REVIPIC"
77151745
REVIPIC
2007-04-09
RETIGMO
"RETIGMO"
77148448
RETIGMO
2007-04-04
MASURVO
"MASURVO"
77137293
MASURVO
2007-03-22
SANSCNI
"SANSCNI"
77137290
SANSCNI
2007-03-22
LORIZAL
"LORIZAL"
77137291
LORIZAL
2007-03-22
LORIZAR
"LORIZAR"
77137292
LORIZAR
2007-03-22
DURMAB
"DURMAB"
77135003
DURMAB
2007-03-20
OH, YES I CAN!
"OH, YES I CAN!"
3785141 77134259
OH, YES I CAN!
2007-03-19
DEPLETE
"DEPLETE"
77125821
DEPLETE
2007-03-08
RESERVE
"RESERVE"
77125814
RESERVE
2007-03-08
DETERMINE
"DETERMINE"
77125816
DETERMINE
2007-03-08
ANSWER
"ANSWER"
77124132
ANSWER
2007-03-07
ASSESS
"ASSESS"
77124135
ASSESS
2007-03-07
ATTEST
"ATTEST"
77124138
ATTEST
2007-03-07
ANALYSE
"ANALYSE"
77124124
ANALYSE
2007-03-07
ADVISE
"ADVISE"
77124118
ADVISE
2007-03-07
ARISTOPHANES
"ARISTOPHANES"
77112231
ARISTOPHANES
2007-02-21
ACADEMY
"ACADEMY"
77112239
ACADEMY
2007-02-21
ALEXANDER
"ALEXANDER"
77109570
ALEXANDER
2007-02-16
RECEPA
"RECEPA"
77102681
RECEPA
2007-02-08
GARIKAD
"GARIKAD"
77102653
GARIKAD
2007-02-08
RENZEPA
"RENZEPA"
77102661
RENZEPA
2007-02-08
TANTARG
"TANTARG"
77102668
TANTARG
2007-02-08
HEART BEAT
"HEART BEAT"
77101571
HEART BEAT
2007-02-07
AGGRESSIVE DISEASE, VIGOROUS RESEARCH
"AGGRESSIVE DISEASE, VIGOROUS RESEARCH"
77091745
AGGRESSIVE DISEASE, VIGOROUS RESEARCH
2007-01-26
VIVIEN
"VIVIEN"
77091734
VIVIEN
2007-01-26
VIVICA
"VIVICA"
77091738
VIVICA
2007-01-26
APPROPRIATE APIXABAN PROPHYLAXIS IN ONCOLOGY PATIENTS TO EVALUATE REDUCTION IN ADVERSE THROMBOEMBOLIC EVENTS
"APPROPRIATE APIXABAN PROPHYLAXIS IN ONCOLOGY PATIENTS TO EVALUATE REDUCTION IN ADVERSE THROMBOEMBOLIC EVENTS"
77085405
APPROPRIATE APIXABAN PROPHYLAXIS IN ONCOLOGY PATIENTS TO EVALUATE REDUCTION IN ADVERSE THROMBOEMBOLIC EVENTS
2007-01-18
ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY
"ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY"
77085410
ABILITY APIXABAN INVESTIGATION TO LOWER THE INCIDENCE OF THROMBOEMBOLIC EVENTS IN CANCER THERAPY
2007-01-18
ADVOCATE APIXABAN TREATMENT TO LOWER THROMBOEMBOLIC EVENTS IN CANCER
"ADVOCATE APIXABAN TREATMENT TO LOWER THROMBOEMBOLIC EVENTS IN CANCER"
77085420
ADVOCATE APIXABAN TREATMENT TO LOWER THROMBOEMBOLIC EVENTS IN CANCER
2007-01-18
IMMUNOSCIENCE THERAPEUTIC EXCELLENCE
"IMMUNOSCIENCE THERAPEUTIC EXCELLENCE"
77085366
IMMUNOSCIENCE THERAPEUTIC EXCELLENCE
2007-01-18
PLUVARAD
"PLUVARAD"
77084468
PLUVARAD
2007-01-17
PLUVERAD
"PLUVERAD"
77084489
PLUVERAD
2007-01-17
AXECTITUDE
"AXECTITUDE"
77084495
AXECTITUDE
2007-01-17
ACMERAD
"ACMERAD"
77084455
ACMERAD
2007-01-17
ACOMOTAT
"ACOMOTAT"
77084497
ACOMOTAT
2007-01-17
ARKNEV
"ARKNEV"
77084457
ARKNEV
2007-01-17
GARSDAG
"GARSDAG"
77084462
GARSDAG
2007-01-17
RECEPA
"RECEPA"
77083675
RECEPA
2007-01-16
WITHINSIGHT
"WITHINSIGHT"
3873689 77079527
WITHINSIGHT
2007-01-10
LOGEON
"LOGEON"
77076080
LOGEON
2007-01-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed